Katarina has solid and extensive experience of the life science sector having served 25 years in various senior positions in Astra Zeneca, the last few years of which as a member of global Group management as Sustainability and Chief Compliance Officer. She was also CEO of Astra Zeneca in Sweden between 2018 and 2023.

Markus Granlund is a seasoned leader and Board member with extensive strategic and operational experience of leading operations with international customers. He served most recently as CEO of Semcon, where he worked for 16 years.

“I am happy to have recruited Katarina as Chairman of TFS’s Board. Her extensive experience in senior management positions in the life science industry will enable her to add great value. It is also very positive that Markus has agreed to take on the role of acting CEO. We had a productive partnership during Markus’s time as President and CEO of Semcon, and we have worked together on the TFS Board for some time,” says Anders Slettengren, current Chairman of the TFS Board and Executive Vice President, Ratos.

About TFS HealthScience
TFS HealthScience is a global Contract Research Organisation (CRO) that supports biotechnology and pharmaceutical companies throughout their entire clinical development journey. Bringing together nearly 700 professionals, TFS delivers tailored clinical research services in more than 40 countries and supports customers with comprehensive solutions through three strong business models: Clinical Development Services (CDS), which provides full-service support at all stages of the clinical development process, Strategic Resourcing Solutions (SRS), which offers expert insourcing and targeted recruitment services, and Functional Services (FSP), to provide customers with strategic outsourcing solutions.